Dr. Neekesh Dharia, MD
Dr. Neekesh Dharia, MD is a pediatric hematologist oncologist in Boston, MA and has over 10 years of experience in the medical field. He graduated from University of California, San Diego School of Medicine in 2011.
Practice
450 Brookline Ave Boston, MA 02215At a Glance
- Areas of ExpertiseDr. Dharia specializes in the areas of Pediatric Hematology-Oncology & Pediatrics. • See board certifications
Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Dharia's Reviews
Overall Patient Satisfaction
About Me
biography
Dr. Neekesh Dharia, MD is a pediatric hematologist oncologist in Boston, MA and has over 10 years of experience in the medical field. He graduated from University of California, San Diego School of Medicine in 2011.Pediatric Hematology & Oncology
Pediatrics
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Dana-farber Cancer Institute
Fellowship HospitalRonald Reagan Ucla Medical Center
Residency Hospital, 2014University Of California, San Diego School Of Medicine
Medical School, 2011
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkSelective modulation of a pan-essential protein as a therapeutic strategy in cancer, 2021-04-21
A First-Generation Pediatric Cancer Dependency Map, 2021-03-22
Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer, 2018-09-25
EP300 selectively controls the enhancer landscape ofMYCN-amplified neuroblastoma, 2022-03-01
EWS/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma, 2018-01-18
An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML, 2021-09-16
A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma, 2018-11-05
Esterase mutation is a mechanism of resistance to antimalarial compounds, 2017-01-20
Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts, 2022-07-06
Focus on Breast Cancer
Locations
Practice
Compare Providers
Providers shown based on Dr. Dharia's location and specialty. Show more Pediatric Oncologists & Pediatric Hematologists.